United States Non-opioid Analgesic Patch Market Report 2017

Publisher Name :
Date: 04-Dec-2017
No. of pages: 98
Inquire Before Buying

In this report, the United States Non-opioid Analgesic Patch market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Non-opioid Analgesic Patch in these regions, from 2012 to 2022 (forecast).

United States Non-opioid Analgesic Patch market competition by top manufacturers/players, with Non-opioid Analgesic Patch sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- GlaxoSmithKline Plc

- Pfizer, Inc.

- Teikoku Seiyaku Co., Ltd.

- Mylan N.V.

- Hisamitsu Pharmaceutical Co.,Inc

- Acorda Therapeutics, Inc

- Endo International plc

- Allergan

- Teh Seng Pharmaceutical Mfg

- IBSA Institut Biochimque SA

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Lidocaine Patches

- Diclofenac Patches

- Methyl Salicylate Patches

- Capsaicin Patches

- Ketoprofen Patches

- Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Hospital Pharmacies

- Online Pharmacies

- Independent Pharmacies & Drug Stores

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Non-opioid Analgesic Patch Market Report 2017

Table of Contents
United States Non-opioid Analgesic Patch Market Report 2017
1 Non-opioid Analgesic Patch Overview
1.1 Product Overview and Scope of Non-opioid Analgesic Patch
1.2 Classification of Non-opioid Analgesic Patch by Product Category
1.2.1 United States Non-opioid Analgesic Patch Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Non-opioid Analgesic Patch Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Lidocaine Patches
1.2.4 Diclofenac Patches
1.2.5 Methyl Salicylate Patches
1.2.6 Capsaicin Patches
1.2.7 Ketoprofen Patches
1.2.8 Others
1.3 United States Non-opioid Analgesic Patch Market by Application/End Users
1.3.1 United States Non-opioid Analgesic Patch Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Independent Pharmacies & Drug Stores
1.4 United States Non-opioid Analgesic Patch Market by Region
1.4.1 United States Non-opioid Analgesic Patch Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Non-opioid Analgesic Patch Status and Prospect (2012-2022)
1.4.3 Southwest Non-opioid Analgesic Patch Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Non-opioid Analgesic Patch Status and Prospect (2012-2022)
1.4.5 New England Non-opioid Analgesic Patch Status and Prospect (2012-2022)
1.4.6 The South Non-opioid Analgesic Patch Status and Prospect (2012-2022)
1.4.7 The Midwest Non-opioid Analgesic Patch Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Non-opioid Analgesic Patch (2012-2022)
1.5.1 United States Non-opioid Analgesic Patch Sales and Growth Rate (2012-2022)
1.5.2 United States Non-opioid Analgesic Patch Revenue and Growth Rate (2012-2022)
2 United States Non-opioid Analgesic Patch Market Competition by Players/Suppliers
2.1 United States Non-opioid Analgesic Patch Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Non-opioid Analgesic Patch Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Non-opioid Analgesic Patch Average Price by Players/Suppliers (2012-2017)
2.4 United States Non-opioid Analgesic Patch Market Competitive Situation and Trends
2.4.1 United States Non-opioid Analgesic Patch Market Concentration Rate
2.4.2 United States Non-opioid Analgesic Patch Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Non-opioid Analgesic Patch Manufacturing Base Distribution, Sales Area, Product Type
3 United States Non-opioid Analgesic Patch Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Non-opioid Analgesic Patch Sales and Market Share by Region (2012-2017)
3.2 United States Non-opioid Analgesic Patch Revenue and Market Share by Region (2012-2017)
3.3 United States Non-opioid Analgesic Patch Price by Region (2012-2017)
4 United States Non-opioid Analgesic Patch Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Non-opioid Analgesic Patch Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Non-opioid Analgesic Patch Revenue and Market Share by Type (2012-2017)
4.3 United States Non-opioid Analgesic Patch Price by Type (2012-2017)
4.4 United States Non-opioid Analgesic Patch Sales Growth Rate by Type (2012-2017)
5 United States Non-opioid Analgesic Patch Sales (Volume) by Application (2012-2017)
5.1 United States Non-opioid Analgesic Patch Sales and Market Share by Application (2012-2017)
5.2 United States Non-opioid Analgesic Patch Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Non-opioid Analgesic Patch Players/Suppliers Profiles and Sales Data
6.1 GlaxoSmithKline Plc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Non-opioid Analgesic Patch Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GlaxoSmithKline Plc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Pfizer, Inc.
6.2.2 Non-opioid Analgesic Patch Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Pfizer, Inc. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Teikoku Seiyaku Co., Ltd.
6.3.2 Non-opioid Analgesic Patch Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Mylan N.V.
6.4.2 Non-opioid Analgesic Patch Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Mylan N.V. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Hisamitsu Pharmaceutical Co.,Inc
6.5.2 Non-opioid Analgesic Patch Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Acorda Therapeutics, Inc
6.6.2 Non-opioid Analgesic Patch Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Endo International plc
6.7.2 Non-opioid Analgesic Patch Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Endo International plc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Allergan
6.8.2 Non-opioid Analgesic Patch Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Allergan Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Teh Seng Pharmaceutical Mfg
6.9.2 Non-opioid Analgesic Patch Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 IBSA Institut Biochimque SA
6.10.2 Non-opioid Analgesic Patch Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
7 Non-opioid Analgesic Patch Manufacturing Cost Analysis
7.1 Non-opioid Analgesic Patch Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Non-opioid Analgesic Patch
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Non-opioid Analgesic Patch Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Non-opioid Analgesic Patch Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Non-opioid Analgesic Patch Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Non-opioid Analgesic Patch Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Non-opioid Analgesic Patch Sales Volume Forecast by Type (2017-2022)
11.3 United States Non-opioid Analgesic Patch Sales Volume Forecast by Application (2017-2022)
11.4 United States Non-opioid Analgesic Patch Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Non-opioid Analgesic Patch
Figure United States Non-opioid Analgesic Patch Market Size (K Units) by Type (2012-2022)
Figure United States Non-opioid Analgesic Patch Sales Volume Market Share by Type (Product Category) in 2016
Figure Lidocaine Patches Product Picture
Figure Diclofenac Patches Product Picture
Figure Methyl Salicylate Patches Product Picture
Figure Capsaicin Patches Product Picture
Figure Ketoprofen Patches Product Picture
Figure Others Product Picture
Figure United States Non-opioid Analgesic Patch Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Non-opioid Analgesic Patch by Application in 2016
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure Independent Pharmacies & Drug Stores Examples
Table Key Downstream Customer in Independent Pharmacies & Drug Stores
Figure United States Non-opioid Analgesic Patch Market Size (Million USD) by Region (2012-2022)
Figure The West Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Non-opioid Analgesic Patch Sales (K Units) and Growth Rate (2012-2022)
Figure United States Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Non-opioid Analgesic Patch Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Non-opioid Analgesic Patch Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Non-opioid Analgesic Patch Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Non-opioid Analgesic Patch Sales Share by Players/Suppliers
Figure 2017 United States Non-opioid Analgesic Patch Sales Share by Players/Suppliers
Figure United States Non-opioid Analgesic Patch Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Non-opioid Analgesic Patch Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Non-opioid Analgesic Patch Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Non-opioid Analgesic Patch Revenue Share by Players/Suppliers
Figure 2017 United States Non-opioid Analgesic Patch Revenue Share by Players/Suppliers
Table United States Market Non-opioid Analgesic Patch Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Non-opioid Analgesic Patch Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Non-opioid Analgesic Patch Market Share of Top 3 Players/Suppliers
Figure United States Non-opioid Analgesic Patch Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Non-opioid Analgesic Patch Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Non-opioid Analgesic Patch Product Category
Table United States Non-opioid Analgesic Patch Sales (K Units) by Region (2012-2017)
Table United States Non-opioid Analgesic Patch Sales Share by Region (2012-2017)
Figure United States Non-opioid Analgesic Patch Sales Share by Region (2012-2017)
Figure United States Non-opioid Analgesic Patch Sales Market Share by Region in 2016
Table United States Non-opioid Analgesic Patch Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Non-opioid Analgesic Patch Revenue Share by Region (2012-2017)
Figure United States Non-opioid Analgesic Patch Revenue Market Share by Region (2012-2017)
Figure United States Non-opioid Analgesic Patch Revenue Market Share by Region in 2016
Table United States Non-opioid Analgesic Patch Price (USD/Unit) by Region (2012-2017)
Table United States Non-opioid Analgesic Patch Sales (K Units) by Type (2012-2017)
Table United States Non-opioid Analgesic Patch Sales Share by Type (2012-2017)
Figure United States Non-opioid Analgesic Patch Sales Share by Type (2012-2017)
Figure United States Non-opioid Analgesic Patch Sales Market Share by Type in 2016
Table United States Non-opioid Analgesic Patch Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Non-opioid Analgesic Patch Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Non-opioid Analgesic Patch by Type (2012-2017)
Figure Revenue Market Share of Non-opioid Analgesic Patch by Type in 2016
Table United States Non-opioid Analgesic Patch Price (USD/Unit) by Types (2012-2017)
Figure United States Non-opioid Analgesic Patch Sales Growth Rate by Type (2012-2017)
Table United States Non-opioid Analgesic Patch Sales (K Units) by Application (2012-2017)
Table United States Non-opioid Analgesic Patch Sales Market Share by Application (2012-2017)
Figure United States Non-opioid Analgesic Patch Sales Market Share by Application (2012-2017)
Figure United States Non-opioid Analgesic Patch Sales Market Share by Application in 2016
Table United States Non-opioid Analgesic Patch Sales Growth Rate by Application (2012-2017)
Figure United States Non-opioid Analgesic Patch Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Non-opioid Analgesic Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Non-opioid Analgesic Patch Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Non-opioid Analgesic Patch Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Plc Non-opioid Analgesic Patch Revenue Market Share in United States (2012-2017)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. Non-opioid Analgesic Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer, Inc. Non-opioid Analgesic Patch Sales Growth Rate (2012-2017)
Figure Pfizer, Inc. Non-opioid Analgesic Patch Sales Market Share in United States (2012-2017)
Figure Pfizer, Inc. Non-opioid Analgesic Patch Revenue Market Share in United States (2012-2017)
Table Teikoku Seiyaku Co., Ltd. Basic Information List
Table Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Sales Growth Rate (2012-2017)
Figure Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Sales Market Share in United States (2012-2017)
Figure Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Revenue Market Share in United States (2012-2017)
Table Mylan N.V. Basic Information List
Table Mylan N.V. Non-opioid Analgesic Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mylan N.V. Non-opioid Analgesic Patch Sales Growth Rate (2012-2017)
Figure Mylan N.V. Non-opioid Analgesic Patch Sales Market Share in United States (2012-2017)
Figure Mylan N.V. Non-opioid Analgesic Patch Revenue Market Share in United States (2012-2017)
Table Hisamitsu Pharmaceutical Co.,Inc Basic Information List
Table Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Sales Growth Rate (2012-2017)
Figure Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Sales Market Share in United States (2012-2017)
Figure Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Revenue Market Share in United States (2012-2017)
Table Acorda Therapeutics, Inc Basic Information List
Table Acorda Therapeutics, Inc Non-opioid Analgesic Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Acorda Therapeutics, Inc Non-opioid Analgesic Patch Sales Growth Rate (2012-2017)
Figure Acorda Therapeutics, Inc Non-opioid Analgesic Patch Sales Market Share in United States (2012-2017)
Figure Acorda Therapeutics, Inc Non-opioid Analgesic Patch Revenue Market Share in United States (2012-2017)
Table Endo International plc Basic Information List
Table Endo International plc Non-opioid Analgesic Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Endo International plc Non-opioid Analgesic Patch Sales Growth Rate (2012-2017)
Figure Endo International plc Non-opioid Analgesic Patch Sales Market Share in United States (2012-2017)
Figure Endo International plc Non-opioid Analgesic Patch Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan Non-opioid Analgesic Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Non-opioid Analgesic Patch Sales Growth Rate (2012-2017)
Figure Allergan Non-opioid Analgesic Patch Sales Market Share in United States (2012-2017)
Figure Allergan Non-opioid Analgesic Patch Revenue Market Share in United States (2012-2017)
Table Teh Seng Pharmaceutical Mfg Basic Information List
Table Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales Growth Rate (2012-2017)
Figure Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales Market Share in United States (2012-2017)
Figure Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Revenue Market Share in United States (2012-2017)
Table IBSA Institut Biochimque SA Basic Information List
Table IBSA Institut Biochimque SA Non-opioid Analgesic Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure IBSA Institut Biochimque SA Non-opioid Analgesic Patch Sales Growth Rate (2012-2017)
Figure IBSA Institut Biochimque SA Non-opioid Analgesic Patch Sales Market Share in United States (2012-2017)
Figure IBSA Institut Biochimque SA Non-opioid Analgesic Patch Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-opioid Analgesic Patch
Figure Manufacturing Process Analysis of Non-opioid Analgesic Patch
Figure Non-opioid Analgesic Patch Industrial Chain Analysis
Table Raw Materials Sources of Non-opioid Analgesic Patch Major Players/Suppliers in 2016
Table Major Buyers of Non-opioid Analgesic Patch
Table Distributors/Traders List
Figure United States Non-opioid Analgesic Patch Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Non-opioid Analgesic Patch Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Non-opioid Analgesic Patch Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Non-opioid Analgesic Patch Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Non-opioid Analgesic Patch Sales Volume (K Units) Forecast by Type in 2022
Table United States Non-opioid Analgesic Patch Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Non-opioid Analgesic Patch Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Non-opioid Analgesic Patch Sales Volume (K Units) Forecast by Application in 2022
Table United States Non-opioid Analgesic Patch Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Non-opioid Analgesic Patch Sales Volume Share Forecast by Region (2017-2022)
Figure United States Non-opioid Analgesic Patch Sales Volume Share Forecast by Region (2017-2022)
Figure United States Non-opioid Analgesic Patch Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Hairy Cell Leukemia Therapeutics Market Research Report 2017
    Published: 15-Dec-2017        Price: US 2900 Onwards        Pages: 103
    In this report, the global Hairy Cell Leukemia Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hairy Cell Leukemia Therapeutics in these regions, from 2012 to 2022 (forecast), covering - North America - ......
  • Global Rotavirus Infections Drug Market Research Report 2017
    Published: 15-Dec-2017        Price: US 2900 Onwards        Pages: 105
    In this report, the global Rotavirus Infections Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Rotavirus Infections Drug in these regions, from 2012 to 2022 (forecast), covering - North America - Europe ......
  • Global Bronchiectasis Treatment Market Research Report 2017
    Published: 15-Dec-2017        Price: US 2900 Onwards        Pages: 103
    In this report, the global Bronchiectasis Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Bronchiectasis Treatment in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - ......
  • Global Vitiligo Drug Market Research Report 2017
    Published: 15-Dec-2017        Price: US 2900 Onwards        Pages: 102
    In this report, the global Vitiligo Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Vitiligo Drug in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global Aurora Kinase C Market Research Report 2017
    Published: 15-Dec-2017        Price: US 2900 Onwards        Pages: 107
    In this report, the global Aurora Kinase C market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Aurora Kinase C in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Jap......
  • Global Rhabdomyosarcoma Drug Market Research Report 2017
    Published: 15-Dec-2017        Price: US 2900 Onwards        Pages: 113
    In this report, the global Rhabdomyosarcoma Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Rhabdomyosarcoma Drug in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • Global Retinoic Acid Receptor Beta Market Research Report 2017
    Published: 15-Dec-2017        Price: US 2900 Onwards        Pages: 102
    In this report, the global Retinoic Acid Receptor Beta market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Retinoic Acid Receptor Beta in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Global Epstein-Barr Virus (HHV-4) Infections Treatment Market Research Report 2017
    Published: 15-Dec-2017        Price: US 2900 Onwards        Pages: 111
    In this report, the global Epstein-Barr Virus (HHV-4) Infections Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Epstein-Barr Virus (HHV-4) Infections Treatment in these regions, from 2012 to 2022 (forecast), covering......
  • Global Cyclin Dependent Kinase 1 Market Research Report 2017
    Published: 15-Dec-2017        Price: US 2900 Onwards        Pages: 105
    In this report, the global Cyclin Dependent Kinase 1 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cyclin Dependent Kinase 1 in these regions, from 2012 to 2022 (forecast), covering - North America - Europe ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs